0 Commentarii
0 Distribuiri
1369 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
- Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
- Memantine Market Poised for Growth Due to Advancements in Alzheimer's Disease TreatmentMemantine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist primarily used for treating moderate to severe Alzheimer's disease. It functions by regulating glutamate activity and providing neuroprotection against toxicity. Memantine is approved as a treatment option either as a monotherapy or in combination with cholinesterase inhibitors for patients suffering from moderate to...0 Commentarii 0 Distribuiri 277 Views 0 previzualizare
- The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's diseaseThe memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...0 Commentarii 0 Distribuiri 691 Views 0 previzualizare
- The Rising Demand for Alzheimer's Drugs Drives the Memantine MarketMemantine is an orally administered drug used for the treatment of Alzheimer's disease symptoms. It works as an NMDA receptor antagonist. The drug helps improve cognitive functions, memory, thinking skills and ability to perform daily routine activities in patients with moderate to severe Alzheimer's disease. It reduces the effect of glutamate which can damage or kill nerve cells. The Global...0 Commentarii 0 Distribuiri 52 Views 0 previzualizare
- Understanding Memantine: Mechanism of Action, Clinical Efficacy, Dosage, and Safety in Alzheimer's Disease TreatmentClinical StudiesSeveral large clinical trials have evaluated the effectiveness and safety profile of memantine in the treatment of moderate to severe Alzheimer's disease. Some of the key studies are:- The MEM-MD-02 Study: This 24-week study compared memantine 20 mg/day to placebo in nursing home residents with severe Alzheimer's disease. Results showed memantine significantly improved...0 Commentarii 0 Distribuiri 981 Views 0 previzualizare
- Analyzing theMemantine Market: Drivers, Opportunities, and TrendsThis Memantine market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market...0 Commentarii 0 Distribuiri 767 Views 0 previzualizare